Pharma

A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.

Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.

For his upcoming HIMSS26 presentation, ChristianaCare's Greg O'Neill discusses how practical tools like plain language, pictograms, multilingual translation and tailored discharge instructions can boost medication compliance.

Amazon is competing with Walmart in the delivery business and against pharmacies such as CVS and Walgreens.

The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.

Patients can see the discounted prices on TrumpRx.gov, but the site does not currently sell the drugs.

AION Labs CEO, Mati Gill, discusses the company’s extensive backing from pharma and tech giants to build AI startups, and how AION is looking beyond AI to explore quantum technologies for research and development in drug discovery.

AION Labs CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss the acquisition he says represents a milestone for Israel’s biotech ecosystem.

Outside the JPM Healthcare Conference, Thomas Clozel, cofounder and CEO of Owkin, sat down with MobiHealthNews to discuss how the company is using AI to find causality in disease.